Keyphrases
Orally Disintegrating Tablet
54%
Liposomes
47%
Amino Acids
35%
Lyophilization
27%
Disintegration Time
21%
Environmental Scanning Electron Microscopy
20%
Dosage Forms
18%
Mannitol
16%
Fast Disintegrating Tablets
16%
Dry Particle Coating
16%
Solid Dispersion
15%
Drug Delivery
14%
Poorly Water-soluble Drugs
14%
Pediatric
14%
Gelatin
13%
Microparticles
13%
Indomethacin
13%
Orally Disintegrating
11%
Arginine
10%
Particle Size
10%
Formulation Development
10%
Drug Development
9%
Fixed-dose Combination
9%
Functional Particles
9%
Ciprofloxacin
9%
Lipids
9%
Pediatric Drug Development
9%
Counterion
9%
PGA-co-PDL
8%
Cholesterol
8%
Lysine
8%
Age-appropriate
8%
Lipid-based Formulation
8%
Delivery System
8%
Microcrystalline Cellulose
8%
Formulation Strategies
8%
Content Uniformity
8%
Dry Coating
7%
Pediatric Population
7%
Niosomes
7%
Liposomal Vaccine
7%
Physiologically-based Pharmacokinetic Model
7%
Virtual Clinical Trials
7%
Approaches to Study
7%
Acidic Amino Acid
7%
Systematic Evaluation
7%
Pharmaceutical Drugs
7%
Dry Powder Coating
7%
Trimethoprim
7%
Scanning Electron Microscope Imaging
7%
Pharmacology, Toxicology and Pharmaceutical Science
Tablet
100%
Amino Acid
43%
Excipient
36%
Liposome
34%
Dosage Forms
30%
Pharmacokinetics
19%
Indometacin
16%
Drug Development
15%
Microparticle
15%
Bioavailability
15%
Mannitol
13%
Clinical Trial
13%
Scanning Electron Microscopy
13%
Adjuvant
12%
Gelatin
11%
Arginine
10%
Ciprofloxacin
9%
Lysine
9%
Biopharmaceutical
8%
Diseases
8%
Counterion
8%
Staphylococcus Aureus
8%
Microcrystalline Cellulose
7%
Disintegrating Agent
7%
Effusion
7%
Cryoprotective Agent
7%
Trimethoprim
7%
Pharmaceutics
7%
Surfactant
7%
Aspartic Acid
7%
Amlodipine
6%
Bioequivalence
6%
Differential Scanning Calorimetry
6%
Immunogenicity
6%
Drug Absorption
6%
Glutamic Acid
6%
Poloxamer
6%
Drug Release
6%
High-Throughput Screening
6%
Pharmacodynamics
6%
Table Salt
5%
Antimicrobial Resistance
5%
Vancomycin
5%
Macrogol 8000
5%
Polyethylene Glycol
5%
Ibuprofen
5%
Drug Discovery
5%
Active Pharmaceutical Ingredient
5%